Levo Y, Shouval D, Tur-Kaspa R, Wollner S, Penchas S, Zlotnick A
Clin Exp Immunol. 1981; 44(1):63-7.
PMID: 6973434
PMC: 1537213.
Fattovich G, Alberti A, Crivellaro C, Pontisso P, Noventa F, Realdi G
Clin Exp Immunol. 1983; 53(3):645-50.
PMID: 6616959
PMC: 1535662.
Pontisso P, Poon M, Tiollais P, Brechot C
Br Med J (Clin Res Ed). 1984; 288(6430):1563-6.
PMID: 6426645
PMC: 1441279.
DOI: 10.1136/bmj.288.6430.1563.
Koszinowski U, Schober A, THOMSSEN R
Med Microbiol Immunol. 1974; 159(3):243-50.
PMID: 4830937
DOI: 10.1007/BF02121340.
MacSween R, Galbraith I, Thomas M, Watkinson G, LUDLAM G
Clin Exp Immunol. 1973; 15(1):35-42.
PMID: 4765720
PMC: 1553872.
Lymphocyte transformation and leucocyte migration-inhibition by Australia antigen.
Laiwah A, Chaudhuri A, ANDERSON J
Clin Exp Immunol. 1973; 15(1):27-34.
PMID: 4765719
PMC: 1553856.
Serum hepatitis as a persistent infection.
Cossart Y
J Clin Pathol Suppl (R Coll Pathol). 1972; 6:22-7.
PMID: 4616968
PMC: 1347245.
DOI: 10.1136/jcp.s3-6.1.22.
Australia antigen and cell-mediated immunity.
Reisenbuk V, Ioks S
Arch Gesamte Virusforsch. 1974; 45(1-2):141-3.
PMID: 4547148
DOI: 10.1007/BF01240552.
Lymphocyte transformation by phytohaemagglutinin (PHA) and purified protein derivative (PPD) in primary biliary cirrhosis. Evidence of serum inhibitory factors.
MacSween R, Thomas M
Clin Exp Immunol. 1973; 15(4):523-33.
PMID: 4544318
PMC: 1553970.
Inability to detect hepatitis B virus or specific antigens in transformed chimpanzee lymphocytes.
Schable C, Murphy B, Berquist K, Gravelle C, MAYNARD J
Infect Immun. 1974; 10(6):1443-4.
PMID: 4373398
PMC: 423124.
DOI: 10.1128/iai.10.6.1443-1444.1974.
In vitro stimulation of sensitized lymphocytes by herpes simplex virus and vaccinia virus.
Rosenberg G, Farber P, Notkins A
Proc Natl Acad Sci U S A. 1972; 69(3):756-60.
PMID: 4335071
PMC: 426551.
DOI: 10.1073/pnas.69.3.756.
Specific lymphocyte stimulation by purified, heat-inactivated hepatitis-B antigen.
de Gast G, Houwen B, NIEWEG H
Br Med J. 1973; 4(5894):707-9.
PMID: 4204672
PMC: 1587858.
DOI: 10.1136/bmj.4.5894.707.
Serum immunoglobulins, complement component levels and autoantibodies in liver disease.
Thompson R, Carter R, Stokes R, Geddes A, Goodall J
Clin Exp Immunol. 1973; 14(3):335-46.
PMID: 4199089
PMC: 1553834.
Australia antigen and primary biliary cirrhosis.
MacSween R, Laiwah A, Busuttil A, Thomas M, Ross S, Watkinson G
J Clin Pathol. 1973; 26(5):335-9.
PMID: 4197542
PMC: 477729.
DOI: 10.1136/jcp.26.5.335.
Studies on pregnancy-associated globulin.
Horne C, McLay A, Tavadia H, Carmichael I, Mallinson A, Laiwah A
Clin Exp Immunol. 1973; 13(4):603-11.
PMID: 4123823
PMC: 1553736.
Detection of cellular and humoral immunity to hepatitis B surface antigen (HBsAg) in asymptomatic HBsAg carriers.
Sylvan S, Hellstrom U, Lundbergh P
Clin Exp Immunol. 1985; 62(2):288-95.
PMID: 3878745
PMC: 1577451.
Cellular immunity to nucleocapsid and pre-S determinants in asymptomatic carriers of hepatitis B virus.
Vento S, Chen S, OBrien C, Dal Monte P, Eddleston A, Howard C
Immunology. 1987; 62(4):593-8.
PMID: 2448227
PMC: 1454163.
T-lymphocyte number and function and the course of hepatitis B in hemodialysis patients.
de Gast G, Houwen B, VAN DER HEM G, The T
Infect Immun. 1976; 14(5):1138-43.
PMID: 1086288
PMC: 415505.
DOI: 10.1128/iai.14.5.1138-1143.1976.
Studies on the subpopulation and function of peripheral lymphocytes, and inhibitor to PHA stimulation existing in the serum of patients with liver disease.
Nakao M, Mizoguchi Y, Monna T, Yamamoto S, Morisawa S
Gastroenterol Jpn. 1975; 10(4):307-15.
PMID: 1086263
DOI: 10.1007/BF02776361.
Editorial: After type B hepatitis.
Br Med J. 1975; 4(5992):311-2.
PMID: 1081418
PMC: 1675197.
